The Enterprise Value as of December 2025 (TTM) for Zenas BioPharma, Inc. (ZBIO) is 1.55B

According to Zenas BioPharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.55B. This represents a change of 615.72% compared to the average of 217.09M of the last 4 quarters.

Zenas BioPharma, Inc. (ZBIO) Historical Enterprise Value (quarterly & annually)

How has ZBIO Enterprise Value performed in the past?

The mean historical Enterprise Value of Zenas BioPharma, Inc. over the last ten years is 433.06M. The current 1.55B Enterprise Value has changed 35.78% with respect to the historical average. Over the past ten years (40 quarters), ZBIO's Enterprise Value was at its highest in in the September 2023 quarter at 699.46M. The Enterprise Value was at its lowest in in the June 2023 quarter at 0.

Zenas BioPharma, Inc. (ZBIO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Zenas BioPharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Zenas BioPharma, Inc. (ZBIO) Average Enterprise Value

How has ZBIO Enterprise Value performed in the past?

The current Enterprise Value of Zenas BioPharma, Inc. (ZBIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Zenas BioPharma, Inc. (ZBIO) Enterprise Value vs. Peers

How is ZBIO’s Enterprise Value compared to its peers?

Zenas BioPharma, Inc.’s Enterprise Value is greater than Upstream Bio, Inc. (1.46B), greater than Intellia Therapeutics, Inc. (925.20M), less than Syndax Pharmaceuticals, Inc. (1.94B), greater than Wave Life Sciences Ltd. (1.07B), greater than Relay Therapeutics, Inc. (1.33B), greater than Novavax, Inc. (1.10B), greater than Amylyx Pharmaceuticals, Inc. (985.24M), greater than ORIC Pharmaceuticals, Inc. (1.06B), less than Trevi Therapeutics, Inc. (1.67B), greater than Inhibrx Biosciences, Inc. (1.13B),

Build a custom stock screener for Zenas BioPharma, Inc. (ZBIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zenas BioPharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Zenas BioPharma, Inc. (ZBIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Zenas BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.